Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
CGNX vs ESE: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
CGNX Wins Head-to-Head Institutional Verdict (6–0 across 6 Pillars · 7–3 Matrix Metrics)
CGNX Overall Winner
6-Pillar Tally: CGNX 6 – 0 ESE
Matrix Metrics: CGNX 7 – 3 ESE
As of Nov 16, 2026, Cognex Corp (CGNX) is the stronger overall head-to-head candidate over ESCO Technologies, Inc. (ESE) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). CGNX carries a Unified Composite Score of 59.5/100 (HOLD) at $48.06 (24.7x Forward P/E, 25.0% operating margin), whereas ESE carries 44.2/100 (HOLD) at $225.98 (25.1x Forward P/E, 15.7% operating margin).
- Technical & Structure Timing Caution: CGNX is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 35.9); meanwhile ESE is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 38.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Executive Snapshot Side-by-Side Composite Ratings & Technical Regime
Ask Alpha AI About CGNX vs ESE
CGNX
Head-to-Head Winner
Cognex Corp
$48.06
-3.9% 1D
Market Cap
$8.5B
TTM Revenue
$1.13B
Forward P/E
24.7x
Beta / 30D Vol
2.19β · 65% Vol
Unified Composite Score
59.5
HOLD
Tech 45.0
Fund 54.0
Flow 58.0
Mom 60.0
Weinstein Technical Phase
Markdown · Sell / avoid
ESE
ESCO Technologies, Inc.
$225.98
-2.38% 1D
Market Cap
$6.1B
TTM Revenue
$573M
Forward P/E
25.1x
Beta / 30D Vol
1.14β · 44% Vol
Unified Composite Score
44.2
HOLD
Tech 39.0
Fund 56.0
Flow 70.0
Mom 64.0
Weinstein Technical Phase
Markdown · Sell / avoid
6-Pillar Scorecard Institutional Category Breakdown (CGNX 6 – 0 ESE)
1. Valuation Multiples
CGNX
Forward P/E
24.7x
25.1x
Trailing P/E
35.5x
43.7x
PEG Ratio
2.71x
1.67x
EV / Revenue
7.0x
10.7x
2. Growth & Scale
CGNX
Revenue Growth (YoY)
+13.2%
+14.4%
Earnings Growth (YoY)
+400.0%
+24.8%
TTM Revenue (USD)
$1.13B
$573M
Market Cap
$8.5B
$6.1B
3. Profitability & Quality
CGNX
Gross Margin
69.7%
42.0%
Operating Margin
25.0%
15.7%
Net Profit Margin
21.5%
24.4%
Return on Equity (ROE)
15.1%
9.5%
4. Balance Sheet & Cash Flow
CGNX
Cash Generation (TTM)
$286M
$87M
Cash Flow Margin
25.4%
15.2%
Net Cash / Leverage
$624M Net Cash
$25M Net Debt (0.08x D/E)
Dividend Yield
0.66%
0.13%
5. Options & Positioning
CGNX
Options Structure Phase
BREAKDOWN
BREAKDOWN
Current IV / %ile
53.5% (16th %ile)
57.1% (4th %ile)
Put/Call OI Skew
1.96x (Put-Skewed)
N/A
OBV Trend / Tech Phase
ACCUMULATION · Markdown
NEUTRAL · Markdown
6. R&D & Supply-Chain Moat
CGNX
OpEx & R&D Intensity
44.7% of Rev ($503M)
26.3% of Rev ($151M)
90D R&D Disclosures
0 papers
0 papers
Competitive Moat
Scale & Operating Efficiency Moat
Scale & Operating Efficiency Moat
Supply-Chain Role
Scientific & Technical Instruments Operator
Scientific & Technical Instruments Operator
Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table
Core Matrix Wins: CGNX (7) vs ESE (3)| Institutional Metric | CGNX | ESE | Criterion | Row Edge |
|---|---|---|---|---|
| Market Capitalization | $8.5B | $6.1B | CGNX | |
| Trailing P/E Ratio | 35.5x | 43.7x | CGNX | |
| Forward P/E Ratio | 24.7x | 25.1x | CGNX | |
| Revenue Growth (YoY) | +13.2% | +14.4% | ESE | |
| Operating Margin (TTM) | 25.0% | 15.7% | CGNX | |
| Net Profit Margin | 21.5% | 24.4% | ESE | |
| Return on Equity (ROE) | 15.1% | 9.5% | CGNX | |
| 52-Week Range Position | 35% ($35–$73) | 19% ($194–$362) | CGNX | |
| Beta / 30D Volatility | 2.19β · 65% Vol | 1.14β · 44% Vol | ESE | |
| Unified Institutional Score | 59.5 / 100 (HOLD) | 44.2 / 100 (HOLD) | CGNX | |
| Trailing 12M Revenue (USD) | $1.13B | $573M | Scale | |
| Gross Profit Margin (TTM) | 69.7% | 42.0% | Quality | |
| PEG Ratio & EV / Revenue | 2.71x PEG · 7.0x EV/Rev | 1.67x PEG · 10.7x EV/Rev | Valuation | |
| Cash Flow & Balance Sheet | $286M ($624M Net Cash) | $87M ($25M Net Debt (0.08x D/E)) | Solvency |
Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)
1M Horizon
ESE +1.69 pp
3M Horizon
CGNX +2.06 pp
6M Horizon
CGNX +0.15 pp
1Y Horizon
CGNX +25.48 pp
Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | CGNX Revenue | ESE Revenue | CGNX Op. Margin | ESE Op. Margin | Margin Leader |
|---|---|---|---|---|---|
| FY2018 | $810M | $680M | 27.4% | 13.5% | CGNX |
| FY2019 | $730M | $730M | 19.7% | 11.2% | CGNX |
| FY2020 | $810M | $730M | 21.0% | 13.6% | CGNX |
| FY2021 | $1.04B | $720M | 30.4% | 8.9% | CGNX |
| FY2022 | $1.01B | $860M | 24.5% | 9.6% | CGNX |
| FY2023 | $840M | $860M | 15.6% | 13.9% | CGNX |
| FY2024 | $910M | $920M | 12.6% | 15.9% | ESE |
| FY2025 | $990M | $1.10B | 16.3% | 15.6% | CGNX |
Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor
Live Options Phase Tracker
CGNX
BREAKDOWN
Current IV
53.5%
IV Percentile
16th %ile
Put/Call OI Skew
1.96x (Put-Skewed)
IV Regime
Compressed (<25th %ile)
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
NEUTRAL
OBV Flow
ACCUMULATION
Exact CGNX Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro.
Unlock 14-Day Free Trial →
ESE
BREAKDOWN
Current IV
57.1%
IV Percentile
4th %ile
Put/Call OI Skew
N/A
IV Regime
Compressed (<25th %ile)
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
BULLISH
OBV Flow
NEUTRAL
Exact ESE Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro.
Unlock 14-Day Free Trial →
Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity
Corporate R&D & Foundry Leaderboard
CGNX Moat Profile
Scale & Operating Efficiency Moat
Scientific & Technical Instruments Operator
OpEx & R&D Reinvestment
44.7% of Rev ($503M)
90D Engineering Disclosures
0 Published
ESE Moat Profile
Scale & Operating Efficiency Moat
Scientific & Technical Instruments Operator
OpEx & R&D Reinvestment
26.3% of Rev ($151M)
90D Engineering Disclosures
0 Published
Investor FAQ CGNX vs ESE Key Questions & Quantitative Answers
As of Nov 16, 2026, Cognex Corp (CGNX) is the stronger overall head-to-head candidate over ESCO Technologies, Inc. (ESE) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). CGNX carries a Unified Composite Score of 59.5/100 (HOLD) at $48.06 (24.7x Forward P/E, 25.0% operating margin), whereas ESE carries 44.2/100 (HOLD) at $225.98 (25.1x Forward P/E, 15.7% operating margin). Technical & Structure Timing Caution: CGNX is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 35.9); meanwhile ESE is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 38.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
CGNX leads the Growth & Scale pillar: CGNX posts +13.2% YoY revenue growth and +400.0% YoY earnings growth on $1.13B TTM revenue (69.7% gross margin, 25.0% operating margin), compared with ESE at +14.4% YoY revenue growth and +24.8% YoY earnings growth on $573M TTM revenue (42.0% gross margin, 15.7% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), CGNX cumulative revenue shifted +22.2% while ESE shifted +61.8%. In operating R&D and SG&A reinvestment, CGNX deploys 44.7% of Rev ($503M) (0 90-day corporate R&D disclosures) versus 26.3% of Rev ($151M) (0 disclosures) for ESE.
CGNX screens cheaper on headline valuation multiples. CGNX trades at 24.7x Forward P/E, 35.5x Trailing P/E, 2.71x PEG, and 7.0x EV/Revenue (25.4% FCF margin), whereas ESE trades at 25.1x Forward P/E, 43.7x Trailing P/E, 1.67x PEG, and 10.7x EV/Revenue (15.2% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against CGNX (15.1% ROE) versus ESE (9.5% ROE) capital efficiency.
In options market volatility and institutional positioning, CGNX carries 53.5% implied volatility (16th %ile, Compressed (<25th %ile)), a 1.96x (Put-Skewed) Put/Call open-interest ratio, ACCUMULATION on-balance volume, and sits in a BREAKDOWN options structure phase (2.19β · 65% Vol realized risk). By comparison, ESE carries 57.1% implied volatility (4th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in a BREAKDOWN options structure phase (1.14β · 44% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Launch Custom Ticker Comparison →
ESE vs CGNX · Reverse Pair
CGNX vs ZBRA
· Sector Peer
CGNX vs ROK
· Sector Peer
CGNX vs IPGP
· Sector Peer
ESE vs BMI
· Sector Peer
ESE vs FELE
· Sector Peer
INTC vs AMD
· x86 & Data Center CPU
NVDA vs AMD
· AI Accelerators
TSM vs ASML
· Foundry & Lithography
MSFT vs GOOGL
· Hyperscale Cloud & AI
AAPL vs META
· Consumer Ecosystem